pharmaphorum

APRIL 26, 2021

Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive disorder. Jolly Good has already won a “Home Healthcare Award” in a programme held by Teijin in December last year.

Development 122

Development Medicine Production Marketing 122

pharmaphorum

JANUARY 11, 2022

A prescription digital therapeutic (DTx) for leukaemia patients developed by Blue Note Therapeutics has been awarded breakthrough device status by the FDA. Last year, Biofourmis said its heart failure tool BiovitalsHF was the first DTx to be awarded breakthrough status by the FDA.

Development 64

Development Production Drugs 64

XTalks

DECEMBER 21, 2022

This included greater adoption and acceptance of decentralized clinical trial models, emphasis on patient-centric approaches in trials, growing digitization of healthcare and dealing with drug manufacturing challenges. These technologies are enabling a broader shift towards the digitalization of healthcare including clinical research.

Life Science 52

Life Science Gene Therapy Gene Clinical Trials 52

XTalks

FEBRUARY 27, 2024

Both therapies were awarded their approvals on the same day in December 2023. Despite high price tags of a couple of million dollars, gene therapy makers say they are working to ensure patients are able to access the treatments through patient assistance programs developed in conjunction with the support of governments.

Research 59

Research Drugs Gene Therapy Clinical Trials 59

The Pharma Data

NOVEMBER 9, 2020

by Natasha Mudhar, Founder of the global social impact enterprise The World We Want , and supported by the World Health Organization , is now officially available for download worldwide from leading digital music stores such as iTunes, Spotify and Amazon Music. WeAreFamily #COVID19 #HealthforAll and tag @WHO, @The_WorldWeWant and @thewhof.

Nurses 40

Nurses Doctors Doctor Scientist 40